L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) ha signat un acord de llic\u00e8ncia amb l\u2019empresa Janus Developments d\u2019una patent corresponent a un producte immunomodulador per al tractament d\u2019afeccions immunol\u00f2giques com ara malalties autoimmunit\u00e0ries, s\u00e8psies, trastorns d\u2019hipersensibilitat (entre els quals, les reaccions al\u00b7l\u00e8rgiques) o rebuig post-trasplantament. La patent ha estat desenvolupada per l\u2019investigador del grup de Gen\u00e8tica Molecular Humana Josep Maria Aran i el seu equip de recerca.<\/p>\n
La invenci\u00f3 est\u00e0 relacionada amb una forma concreta de la prote\u00efna C4BP (C4b-binding protein), que \u00e9s capa\u00e7 d\u2019inhibir altres prote\u00efnes del sistema de complement, un component fonamental de la resposta immunit\u00e0ria innata.<\/p>\n
Encara hauran de passar molts anys abans que el producte desenvolupat pel Dr. Aran pugui ser aplicat en humans. Faran falta m\u00e9s estudis precl\u00ednics i la realitzaci\u00f3 d\u2019assaigs cl\u00ednics en humans. En aquest sentit, la signatura del contracte de llic\u00e8ncia suposa un pas important per poder completar aquests estudis i convertir en un futur aquest producte en un medicament.<\/p>\n
La responsable de l\u2019Oficina de Transfer\u00e8ncia de Resultats de la Investigaci\u00f3 (OTRI) de l\u2019IDIBELL, Montse Ballar\u00edn, destaca que el fet de \u201cllicenciar els productes desenvolupats a la nostra instituci\u00f3 respon a l\u2019estrat\u00e8gia de l\u2019IDIBELL, com a centre de recerca p\u00fablic, per fer arribar les nostres idees i invencions fins al mercat\u201d.<\/p>\n
Ballar\u00edn destaca que la transfer\u00e8ncia d\u2018una tecnologia o d\u2019un producte a l\u2019empresa no \u00e9s un proc\u00e9s f\u00e0cil. \u201cCal oferir un bon producte, que respongui a una necessitat del mercat, que resolgui un problema no resolt, que la seva producci\u00f3 sigui t\u00e8cnicament i econ\u00f2micament viable, que el sistema sanitari estigui disposat a comprar-lo i una llarga llista de condicionants que cal superar abans d\u2019aconseguir l\u2019inter\u00e8s de l\u2019empresa\u201d. Finalment, explica la responsable de l\u2019OTRI, \u201ccal una bona negociaci\u00f3 per tal de protegir adequadament els interessos dels inventors i de la instituci\u00f3\u201d.<\/p>\n
Janus Developments \u00e9s una empresa dedicada a la transfer\u00e8ncia de coneixement biom\u00e8dic cap al mercat. Actualment desenvolupa onze projectes basats en patents originades a diverses universitats i centres de recerca. A m\u00e9s, Janus col\u00b7labora de manera puntual en la definici\u00f3 i la implantaci\u00f3 de diverses empreses i fundacions. Janus Developments d\u00f3na suport a l\u2019IDIBELL en les activitats de transfer\u00e8ncia, des de la identificaci\u00f3 de tecnologies fins a la seva comercialitzaci\u00f3.<\/p>\n
La llic\u00e8ncia signada amb Janus ha estat la primera patent que l\u2019IDIBELL, a trav\u00e9s de la seva OTRI, ha transferit a una empresa de fora del campus (anteriorment s\u2019havien aconseguit contractes de llic\u00e8ncia amb empreses derivades, sorgides de la instituci\u00f3). La patent transferida a Janus ha estat possible gr\u00e0cies al suport del Ministeri d\u2019Economia i Competitivitat, del Instituto de Salud Carlos III i dels fons europeus per al desenvolupament regional (FEDER).<\/p>\n
Recentment tamb\u00e9 s\u2019ha transferit una tecnologia diagn\u00f2stica i una patent a una multinacional farmac\u00e8utica. En aquest moment, l\u2019IDIBELL est\u00e0 en vies de tancar dos acords de llic\u00e8ncia m\u00e9s de dues patents desenvolupades per investigadors del centre.<\/p>\n","protected":false},"excerpt":{"rendered":"
L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) ha signat un acord de llic\u00e8ncia amb l\u2019empresa Janus Developments d\u2019una patent corresponent a un producte immunomodulador per al tractament d\u2019afeccions immunol\u00f2giques com ara malalties autoimmunit\u00e0ries, s\u00e8psies, trastorns d\u2019hipersensibilitat (entre els quals, les reaccions al\u00b7l\u00e8rgiques) o rebuig post-trasplantament. La patent ha estat desenvolupada per l\u2019investigador del grup de Gen\u00e8tica […]<\/p>\n","protected":false},"author":6,"featured_media":20756,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[334,464,378],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-04 11:39:55","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9423"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=9423"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9423\/revisions"}],"predecessor-version":[{"id":20757,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/9423\/revisions\/20757"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/20756"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=9423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=9423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=9423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}